Originally broadcast: Tuesday, 5th May 2020
Duration: 60 minutes. Available to watch on demand
Consider why we need economic evaluations
Explain what a QALY is
Describe how to derive utility
Recognise the advantages of modelling
Understand the importance of developing early health economic models
Identify types of early health economic models
Understand types of analyses in early health economic models
Discuss lessons learnt from HTA bodies’ critique of models using case studies
The Pharma and MedTech job functions that will benefit most include:
Heads of Market Access
Policy Officers and Executives
If you are unable to join the live Webinar, please still register and we will forward the slide decks afterwards.
Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281
VAT Group Registration Number:
GB 292 8576 52